Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss. Two individuals have been arrested, and a nationwide alert has been issued to detect the fake injections.
Companies are already diversifying sourcing, raising prices, and reworking operating models as the disruption drags on.
For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.
Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.
The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.
A woman Food Safety Officer was targeted by suspected gutkha mafia operatives during a raid in Maharashtra's Chhatrapati Sambhajinagar district. The incident, where a vehicle attempted to run her over, has led the state government to order strict action against those responsible. FDA Minister Narhari Zirwal condemned the attack and assured full support to the officer, vowing no leniency for assailants of government officials.
The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.
Mexico is facing widespread violence and travel advisories after the death of drug lord 'El Mencho,' the notorious leader of the Jalisco New Generation Cartel, during a military operation.
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.
Maharashtra FDA seizes 5,929 kg of toxic methanol from a warehouse in Thane district, allegedly linked to spurious liquor that caused 14 deaths in Pune and Pimpri-Chinchwad.
Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.
Tamil Nadu Government will take criminal action against a drug manufacturer, whose cough syrup has been banned in the wake of children's deaths in Madhya Pradesh, state minister Ma Subramanian said here on Wednesday.
Jharkhand Police seized narcotics and illicit liquor worth over Rs 2.54 crore and arrested seven persons in separate operations across five districts.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
Delhi High Court has cleared the way for Zydus Lifesciences to proceed with the sale of its version of the cancer drug nivolumab in India. nivolumab is used to treat several types of cancer by activating the body's immune system to target carcinogenic cells.
Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.
United States Senator Jim Banks has urged the Food and Drug Administration (FDA) to step up inspections of overseas pharmaceutical manufacturing facilities, expressing concern over poor-quality drugs being imported from countries like India and China.
Pharmaceutical major Cipla reported a 3 per cent year-on-year decline in March quarter revenue to Rs 6,541 crore, with net profit falling 55 per cent to Rs 554.6 crore, missing consensus estimates. Despite strong growth in India and Africa, a significant decline in North American sales impacted overall performance, with the company now focusing on new product launches and regulatory filings to drive future gains.
Bollywood actor-director Siddhanth Kapoor was questioned by Mumbai police in connection with a drug seizure case. The Anti-Narcotics Cell (ANC) also summoned influencer Orhan Awatramani. The investigation is linked to a Rs 252 crore mephedrone seizure case.
The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Kaysons Pharma following reports of children's deaths allegedly linked to contaminated cough syrup.
Sitharaman in her budget speech said that the customs proposal "aim to further simplify the tariff structure, support domestic manufacturing, promote export competitiveness, and correct inversion in duty".
The Enforcement Directorate (ED) raided premises linked to Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup linked to the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA as part of a money laundering investigation.
The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.
'...would obesity still be a global epidemic?'
A new law is being proposed to grant statutory powers to the Central Drugs Standard Control Organisation to regulate the manufacture, distribution, and sale of drugs, medical devices, and cosmetics.
Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.
India and New Zealand have signed a comprehensive Free Trade Agreement (FTA) aimed at significantly boosting bilateral commerce and investments, providing duty-free access for 100 per cent of India's exports to New Zealand and securing duty-free inputs for India's manufacturing sector.
Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
In a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday.
A 56-year-old man from Delhi has been arrested for allegedly manufacturing and selling counterfeit weight loss powder and spurious Ayurvedic products online using duplicate branding.
India's home-grown EV startups say the government's auto PLI scheme is helping big players while shutting out innovators building electric two- and three-wheelers from scratch.
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
A Delhi court acquitted two men accused of possessing heroin, citing the prosecution's failure to prove its case due to a lack of independent witnesses and contradictions in police testimonies.
Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a potentially carcinogenic chemical -- N-Nitrosodimethylamine -- in antacid Ranitidine.
India and the United States are committed to finalising an interim trade agreement, despite recent challenges including the US imposing a blanket 10 per cent surcharge and India's decision to wait for a new global tariff architecture. The US Trade Representative's annual report highlights India's maintained high import tariffs and various non-tariff barriers across several sectors.
As many as 17 cancer drugs, along with medicines and food for special medical needs for seven rare diseases, components for microwave ovens are some of the items that are set to become cheaper with Finance Minister Nirmala Sitharaman announcing cuts in customs duty in the Union Budget 2026-27.
A total of 149 kgs of mephedrone or 'meow meow' drug (both in powder and liquid form), 50 kg ephedrine, and 200 litres of acetone was recovered from the three labs located in Bhinmal of Jalore district and Osian in Jodhpur district of Rajasthan and Gandhinagar in Gujarat, the officer said.